医学
血清素综合征
5-羟色胺能
儿科
神经认知
多药
阿立哌唑
麻醉
内科学
脊髓病
痴呆
神经影像学
肌阵挛
血清素
氟哌啶醇
药物治疗
脑干
帕罗西汀
疾病
巴氯芬
运动障碍
萎缩
皮质脊髓束
可乐定
萧条(经济学)
5-羟色胺再摄取抑制剂
曲唑酮
舍曲林
离子通道病
锥体外系症状
作者
Jainam Shah,Andrew Parsons,Sachin Pathuri,Joshua Lieberman,Candace Hatten-Powell
出处
期刊:Case Reports
[BMJ]
日期:2025-09-01
卷期号:18 (9): e267753-e267753
被引量:1
标识
DOI:10.1136/bcr-2025-267753
摘要
Serotonin syndrome is a life-threatening condition characterized by neuromuscular hyperactivity, autonomic dysregulation and altered mental status. Polypharmacy in older adults with multiple comorbidities is associated with increased risk of serotonin syndrome. We report a woman in her 50s with diabetes, hypertension and chronic kidney disease recently misdiagnosed with Parkinsonism. She presented with confusion, hyperreflexia, myoclonus and autonomic instability. Her medications included supratherapeutic paroxetine (40mg two times per day), aripiprazole and benztropine. Symptoms improved with cyproheptadine and cessation of serotonergic agents. However, persistent motor findings prompted further evaluation. Cervical spine MRI showed C4-C5 disc protrusion with ventral cord compression, while brain imaging revealed cerebral atrophy. Cautious administration of haloperidol did not worsen symptoms, suggesting drug-induced or structural Parkinsonism. This case highlights the risk of uncoordinated pharmacotherapy and premature diagnostic closure. The presentation of serotonin syndrome may obscure underlying neurologic pathology, making thorough medication review and multidisciplinary evaluation essential in complex geriatric presentations.
科研通智能强力驱动
Strongly Powered by AbleSci AI